目的研究跨膜型血管内皮生长因子受体1(Flt-1)在子痫前期患者胎楹组织中的表达变化及其意义。方法采用RT—PCR方法检测20例子痫前期患者(观察组)胎盘组织中Flt-1 mRNA的相对表达量[以Flt-1与β肌动蛋白(β—actin)电泳条带吸光度(A)值的比值表示],并以20例正常孕妇(对照组)为对照;采用蛋白印迹(western blot)法检测和比较两组各18例胎盘组织中Flt-1的蛋白相对表达量[其余4例标本因蛋白提取不理想而废弃,以Flt-1与磷酸甘油醛脱氧酶(GAPDH)电泳条带,4值的比值表示]。结果两组孕妇胎盘组织中均有Flt-1的表达。观察组孕妇胎盘组织Flt-1 mRNA相对表达量为2.25±0.19,对照组为1.23±0.29,两组比较,差异有统计学意义(P〈0.05);观察组孕妇胎盘组织Flt-1蛋白相对表达量为2.67±1.19,对照组为0.94±0.51,两组比较,差异也有统计学意义(P〈0.05)。结论Flt-1可能参与子痫前期的病理生理过程。
Objective To investigate the expression of fins-like tyrosine kinase receptor 1 ( Flt-1 ) in placentas of pre-eclampsia. Methods The expression of Flt-1 mRNA in the placentas from 20 preeclampsia patients and 20 pregnant women with normal blood pressure was detected by semi-quantitative reverse transcription-polymerase chain reaction. The protein expression of Flt-1 was analyzed using western blot in 18 pre-eclampsia patients and 18 normotensive pregnant women. Results Placental Flt-1 mRNA level in pre-eclampsia was 2. 25 ± 0. 19 ( intensity ratios of Fh-1 mRNA to β-actin mRNA) , significantly higher than in normotensive pregnant women 1.23± 0. 29 ( P 〈 0. 05 ). Western blot showed that Flt-1 protein level in pre-eclamptic placenta was 2. 67 ± 1. 19 [ western blot signal intensity ratios of Flt-1 to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ] , significantly higher than in pregnant women with normal blood pressure 0. 94 ± 0. 51 ( P 〈 0. 05 ). Conclusion Increased Flt-1 expression in pre-eclamptic placenta may be involved in pathogenesis of pre-eclampsia.